These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29885105)

  • 1. Insulin Resistance and the Risk of Diabetes and Dysglycemia in Korean General Adult Population.
    Baek JH; Kim H; Kim KY; Jung J
    Diabetes Metab J; 2018 Aug; 42(4):296-307. PubMed ID: 29885105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify Dysglycemia and Type 2 Diabetes Mellitus: A 15-Year Prospective Study in Chinese.
    Lee CH; Shih AZ; Woo YC; Fong CH; Leung OY; Janus E; Cheung BM; Lam KS
    PLoS One; 2016; 11(9):e0163424. PubMed ID: 27658115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.
    Ghasemi A; Tohidi M; Derakhshan A; Hasheminia M; Azizi F; Hadaegh F
    Acta Diabetol; 2015 Oct; 52(5):905-15. PubMed ID: 25794879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) Cut-Offs: A Cross-Sectional Study in the Czech Population.
    Horáková D; Štěpánek L; Janout V; Janoutová J; Pastucha D; Kollárová H; Petráková A; Štěpánek L; Husár R; Martiník K
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31108989
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.
    Gayoso-Diz P; Otero-González A; Rodriguez-Alvarez MX; Gude F; García F; De Francisco A; Quintela AG
    BMC Endocr Disord; 2013 Oct; 13():47. PubMed ID: 24131857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study.
    Stabe C; Vasques AC; Lima MM; Tambascia MA; Pareja JC; Yamanaka A; Geloneze B
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):874-81. PubMed ID: 22804918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults.
    Seo YG; Song HJ; Song YR
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):710-725. PubMed ID: 32030917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Resistance Distribution and Cut-Off Value in Koreans from the 2008-2010 Korean National Health and Nutrition Examination Survey.
    Yun KJ; Han K; Kim MK; Park YM; Baek KH; Song KH; Kwon HS
    PLoS One; 2016; 11(4):e0154593. PubMed ID: 27128847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio is a more powerful marker than TyG index for predicting metabolic syndrome in patients with type 2 diabetes mellitus.
    Gong S; Gan S; Zhang Y; Zhou H; Zhou Q
    Front Endocrinol (Lausanne); 2023; 14():1248614. PubMed ID: 37854188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007).
    Esteghamati A; Ashraf H; Khalilzadeh O; Zandieh A; Nakhjavani M; Rashidi A; Haghazali M; Asgari F
    Nutr Metab (Lond); 2010 Apr; 7():26. PubMed ID: 20374655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Novel Biomarkers of Insulin Resistance With Homeostasis Model Assessment of Insulin Resistance, Its Correlation to Metabolic Syndrome in South Indian Population and Proposition of Population Specific Cutoffs for These Indices.
    Jog KS; Eagappan S; Santharam RK; Subbiah S
    Cureus; 2023 Jan; 15(1):e33653. PubMed ID: 36788883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The difference in correlation between insulin resistance index and chronic inflammation in type 2 diabetes with and without metabolic syndrome.
    Pourfarzam M; Zadhoush F; Sadeghi M
    Adv Biomed Res; 2016; 5():153. PubMed ID: 27713874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cut-off Values and Clinical Utility of Surrogate Markers for Insulin Resistance and Beta-Cell Function to Identify Metabolic Syndrome and Its Components among Southern Indian Adults.
    Endukuru CK; Gaur GS; Yerrabelli D; Sahoo J; Vairappan B
    J Obes Metab Syndr; 2020 Dec; 29(4):281-291. PubMed ID: 33229629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study.
    Yi KH; Hwang JS; Kim EY; Lee SH; Kim DH; Lim JS
    Diabetes Res Clin Pract; 2014 Jan; 103(1):106-13. PubMed ID: 24290751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents.
    Widjaja NA; Irawan R; Hanindita MH; Ugrasena I; Handajani R
    J Med Invest; 2023; 70(1.2):7-16. PubMed ID: 37164746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic score of insulin resistance is positively correlated with bone mineral density in postmenopausal patients with type 2 diabetes mellitus.
    Gu P; Pu B; Xin Q; Yue D; Luo L; Tao J; Li H; Chen M; Hu M; Hu X; Zheng X; Zeng Z
    Sci Rep; 2023 May; 13(1):8796. PubMed ID: 37258550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the Predictive Power of Surrogate Diagnostic Indices for Identifying Individuals with Metabolic Syndrome.
    Hosseinkhani S; Forouzanfar K; Hadizadeh N; Razi F; Darzi S; Bandarian F
    Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38258774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome.
    Son DH; Lee HS; Lee YJ; Lee JH; Han JH
    Nutr Metab Cardiovasc Dis; 2022 Mar; 32(3):596-604. PubMed ID: 35090800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.